Factors associated with compliance in treatment of tuberculosis

Tubercle and Lung Disease

Volumn 74, Issue 1, 1993, Pages 32-37

  Menzies, R ^a   Rocher, I ^b   Vissandjee, B ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; CHEMOPROPHYLAXIS; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT EDUCATION; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN; MALE; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; TUBERCULOSIS, PULMONARY;

EID: 0027535195     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1016/0962-8479(93)90066-7     Document Type: Article

References (22)

1. Patient compliance: the most serious remaining problem in the control of tuberculosis in the United States
2. Enhancing patient compliance with tuberculosis therapy
3. Compliance of patients and physicians: experience and lessons from tuberculosis.I
4. Recurrent tuberculosis: why do patients develop disease again?
5. Strategies to improve compliance with therapy
6. Compliance with tuberculosis regimes: results from USPHS therapy trial 21
7. Tuberculosis patients with a high risk of treatment failure
8. International Union Against Tuberculosis
9. Attendance compliance for short course tuberculosis chemotherapy at clinics in Estcourt and surroundings
10. Rifampin-Isoniazid therapy of alcoholic and non-alcoholic tuberculosis patients in a U S Public Health Service cooperative trial
11. New data on preventive treatment with isoniazid
12. The outcome of chemoprophylaxis on tuberculosis prevention in the Canadian plains Indians
13. Methodologic issues in the measurement of patient compliance
14. Measuring patient compliance in the treatment of pulmonary tuberculosis in Cape Town — pitfalls in study design
15. Profiles of noncompliance with anti-tuberculous therapy
16. A patient eduction program to improve adherence rates with antituberculosis drug regimes
17. A critical review of the ‘derterminants’ of patient compliance with therapeutic regimens
18. Compliance in developed nations
19. Misuse of prescription indications by out-patients